Press Releases

Keyword Search

Date Title
09/16/20
 Summary ToggleT2 Biosystems to Participate in Sepsis Alliance Summit Printer Friendly Version Summit will raise awareness and highlight the critical role of rapid diagnostics for bloodstream infections, sepsis and the COVID-19 virus LEXINGTON, Mass. , Sept. 16, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today
09/04/20
 Summary ToggleT2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second Year Printer Friendly Version Payment Covers 65 Percent of the Average Cost of the Test Panel for Eligible Patients LEXINGTON, Mass. , Sept. 04, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S.
08/31/20
 Summary ToggleT2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test Printer Friendly Version The T2SARS-CoV-2™ Panel runs on the FDA-cleared T2Dx® Instrument LEXINGTON, Mass. , Aug. 31, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Food and Drug Administration (FDA) has issued
08/11/20
 Summary ToggleT2 Biosystems Announces Second Quarter 2020 Financial Results Printer Friendly Version LEXINGTON, Mass. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the second quarter ended June 30, 2020 . Recent Highlights Achieved second quarter total revenue of $2.6
08/05/20
 Summary ToggleT2 Biosystems Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split Printer Friendly Version LEXINGTON, Mass. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that its Board of Directors has decided it will not seek authority from the stockholders at the 2020 Annual Meeting (“Annual Meeting”)
07/30/20
 Summary ToggleT2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference Printer Friendly Version LEXINGTON, Mass. , July 30, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference.
07/28/20
 Summary ToggleT2 Biosystems to Report Second Quarter 2020 Financial Results on August 11, 2020 Printer Friendly Version LEXINGTON, Mass. , July 28, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close on Tuesday, August 11, 2020.
06/30/20
 Summary ToggleT2 Biosystems Announces U.S. Launch of COVID-19 Diagnostic Test Printer Friendly Version The T2SARS-CoV-2™ Panel will run on the FDA cleared T2Dx® Instrument LEXINGTON, Mass. , June 30, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the completion of validation of its COVID-19 molecular
06/30/20
 Summary ToggleT2 Biosystems Announces Preliminary Second Quarter 2020 Financial Results Printer Friendly Version Launches the T2SARS-CoV-2™ Panel under FDA EUA Guidelines LEXINGTON, Mass. , June 30, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited preliminary financial result estimates for the quarter ended June
06/26/20
 Summary ToggleT2 Biosystems Reports Granting of Inducement Award Printer Friendly Version LEXINGTON, Mass. , June 26, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to four new employees. The awards were made on May 5, 2020 and June 2, 2020 under T2 Biosystems’